Northwest & Ethical Investments L.P. Acquires 186 Shares of Cigna Group $CI

Northwest & Ethical Investments L.P. increased its holdings in Cigna Group (NYSE:CI) by 1.0% in the second quarter, according to its most recent Form 13F filing with the Securities & Exchange Commission. The firm owned 18,026 shares of the health services provider’s stock after acquiring an additional 186 shares during the quarter. Northwest & Ethical Investments L.P.’s holdings in Cigna Group were worth $5,959,000 as of its most recent filing with the Securities & Exchange Commission.

Several other large investors have also added to or reduced their stakes in the stock. Price T Rowe Associates Inc. MD lifted its position in shares of Cigna Group by 10.0% in the 1st quarter. Price T Rowe Associates Inc. MD now owns 12,056,806 shares of the health services provider’s stock worth $3,966,690,000 after purchasing an additional 1,094,327 shares during the period. Massachusetts Financial Services Co. MA increased its position in shares of Cigna Group by 1.1% during the second quarter. Massachusetts Financial Services Co. MA now owns 11,778,472 shares of the health services provider’s stock valued at $3,893,727,000 after buying an additional 123,479 shares during the period. Dodge & Cox raised its stake in Cigna Group by 1.3% in the first quarter. Dodge & Cox now owns 8,889,733 shares of the health services provider’s stock worth $2,924,722,000 after buying an additional 117,125 shares in the last quarter. GQG Partners LLC lifted its holdings in Cigna Group by 21.5% in the first quarter. GQG Partners LLC now owns 4,886,674 shares of the health services provider’s stock worth $1,607,716,000 after buying an additional 865,092 shares during the period. Finally, Valeo Financial Advisors LLC boosted its position in Cigna Group by 86,071.1% during the 2nd quarter. Valeo Financial Advisors LLC now owns 3,475,282 shares of the health services provider’s stock valued at $1,148,859,000 after acquiring an additional 3,471,249 shares in the last quarter. Institutional investors own 86.99% of the company’s stock.

Wall Street Analysts Forecast Growth

Several research analysts have recently issued reports on CI shares. Weiss Ratings reissued a “hold (c)” rating on shares of Cigna Group in a research report on Tuesday. Guggenheim reduced their price target on Cigna Group from $350.00 to $309.00 in a research note on Friday, October 31st. Zacks Research lowered Cigna Group from a “hold” rating to a “strong sell” rating in a research report on Monday, November 3rd. Raymond James Financial restated a “strong-buy” rating on shares of Cigna Group in a report on Monday, November 3rd. Finally, UBS Group set a $294.00 target price on shares of Cigna Group in a research report on Wednesday, November 12th. One investment analyst has rated the stock with a Strong Buy rating, nineteen have issued a Buy rating, three have issued a Hold rating and one has issued a Sell rating to the company. Based on data from MarketBeat, the company has a consensus rating of “Moderate Buy” and an average target price of $334.05.

Cigna Group Trading Up 0.1%

Cigna Group stock opened at $278.60 on Thursday. Cigna Group has a 12 month low of $239.51 and a 12 month high of $350.00. The company has a market capitalization of $74.42 billion, a price-to-earnings ratio of 15.21, a price-to-earnings-growth ratio of 0.88 and a beta of 0.44. The business’s fifty day simple moving average is $285.55 and its two-hundred day simple moving average is $297.73. The company has a current ratio of 0.71, a quick ratio of 0.71 and a debt-to-equity ratio of 0.65.

Cigna Group (NYSE:CI) last posted its quarterly earnings results on Thursday, October 30th. The health services provider reported $7.83 earnings per share (EPS) for the quarter, topping the consensus estimate of $7.64 by $0.19. The firm had revenue of $69.57 billion during the quarter, compared to analyst estimates of $66.40 billion. Cigna Group had a return on equity of 18.80% and a net margin of 1.92%.Cigna Group’s quarterly revenue was up 9.5% compared to the same quarter last year. During the same quarter in the previous year, the firm earned $7.51 EPS. Cigna Group has set its FY 2025 guidance at 29.600- EPS. As a group, equities analysts predict that Cigna Group will post 29.77 earnings per share for the current fiscal year.

Cigna Group Announces Dividend

The company also recently announced a quarterly dividend, which will be paid on Thursday, December 18th. Stockholders of record on Thursday, December 4th will be paid a $1.51 dividend. This represents a $6.04 annualized dividend and a dividend yield of 2.2%. The ex-dividend date is Thursday, December 4th. Cigna Group’s dividend payout ratio is currently 26.64%.

Insider Activity at Cigna Group

In other Cigna Group news, CEO David Cordani acquired 4,134 shares of the stock in a transaction that occurred on Monday, November 3rd. The shares were acquired at an average cost of $241.88 per share, with a total value of $999,931.92. Following the transaction, the chief executive officer owned 157,935 shares of the company’s stock, valued at $38,201,317.80. The trade was a 2.69% increase in their position. The transaction was disclosed in a filing with the SEC, which can be accessed through this link. Also, insider Brian C. Evanko sold 5,368 shares of Cigna Group stock in a transaction on Friday, October 3rd. The stock was sold at an average price of $300.00, for a total value of $1,610,400.00. Following the completion of the sale, the insider directly owned 51,182 shares of the company’s stock, valued at approximately $15,354,600. The trade was a 9.49% decrease in their position. The disclosure for this sale is available in the SEC filing. Corporate insiders own 0.70% of the company’s stock.

About Cigna Group

The Cigna Group, together with its subsidiaries, provides insurance and related products and services in the United States. Its Evernorth Health Services segment provides a range of coordinated and point solution health services, including pharmacy benefits, home delivery pharmacy, specialty pharmacy, distribution, and care delivery and management solutions to health plans, employers, government organizations, and health care providers.